Amp Capital Investors LTD Takeda Pharmaceutical CO LTD Transaction History

Amp Capital Investors LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$15.39 - $18.97 $468,933 - $578,015	-30,470 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$17.1 - $19.19 $521,037 - $584,719	30,470 New	30,470 $553,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $267,800 - $330,954	-16,152 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$16.7 - $21.52 $1.75 Million - $2.25 Million	-104,616 Reduced 86.63%	16,152 $334,000
Q4 2018 Feb 13, 2019	BUY	$15.64 - $21.1 $1.89 Million - $2.55 Million	120,768 New	120,768 $2.02 Million

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.